| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $220,266,649 ) (Continued on the next page) |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS129549 | Development of an innovative in vivo voltammetric technique for measurements of tonic serotonin concentrations in the mammalian brain. | 000 | 2 | NIH | 11/30/2023 | $525,282 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K08CA279652 | Elucidating the role of IRF4 in reprogramming the tumor microenvironment in follicular lymphoma | 001 | 1 | NIH | 6/11/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K08CA279652 | Elucidating the role of IRF4 in reprogramming the tumor microenvironment in follicular lymphoma | 000 | 1 | NIH | 1/10/2024 | $178,069 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K08DK134759 | Aging lymphocytes: senescence programs in lymphocytes relevant to human inflammatory bowel disease | 000 | 2 | NIH | 11/7/2023 | $163,590 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA271503 | Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma | 001 | 2 | NIH | 4/18/2024 | $26,975 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA271503 | Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma | 000 | 2 | NIH | 12/29/2023 | $485,587 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL142068 | T Cell Immunity in Giant Cell Arteritis | 001 | 5 | NIH | 6/10/2024 | $58,104 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL142068 | T Cell Immunity in Giant Cell Arteritis | 000 | 5 | NIH | 11/29/2023 | $522,936 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB017095 | Diagnostic performance assessment and dose optimization using patient CT images: Application to deep-learning CT reconstruction and denoising technologies | 001 | 10 | NIH | 4/25/2024 | $46,368 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB017095 | Diagnostic performance assessment and dose optimization using patient CT images: Application to deep-learning CT reconstruction and denoising technologies | 000 | 10 | NIH | 12/15/2023 | $540,969 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K01DK124358 | Gastrointestinal Cues Influence Metabolic Control of Regulatory T cell Function | 000 | 5 | NIH | 12/22/2023 | $144,320 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DE029322 | Transcriptome and Network Analysis of Cleft Palate | 005 | 5 | NIH | 7/11/2024 | $58,066 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DE029322 | Transcriptome and Network Analysis of Cleft Palate | 004 | 5 | NIH | 5/15/2024 | $557,250 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DE029322 | Transcriptome and Network Analysis of Cleft Palate | 001 | 5 | NIH | 1/25/2024 | $672,488 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK126827 | Epigenetic dysregulation in diabetic enteric neuropathy | 001 | 4 | NIH | 5/30/2024 | $30,083 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK126827 | Epigenetic dysregulation in diabetic enteric neuropathy | 000 | 4 | NIH | 12/12/2023 | $451,271 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AR076347 | The Role of Cellular Senescence in Carpal Tunnel Syndrome | 001 | 4 | NIH | 6/18/2024 | $46,950 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AR076347 | The Role of Cellular Senescence in Carpal Tunnel Syndrome | 000 | 4 | NIH | 12/7/2023 | $603,632 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK131685 | Noninvasive assessment of detrusor pressure and dysfunction | 000 | 3 | NIH | 1/22/2024 | $560,467 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01GM136869 | Molecular mechanistic studies of long “noncoding” RNAs in mammalian cell differentiation | 000 | 4 | NIH | 12/14/2023 | $286,200 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK126691 | Pathogenesis of Primary Biliary Cholangitis | 001 | 4 | NIH | 5/10/2024 | $38,732 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK126691 | Pathogenesis of Primary Biliary Cholangitis | 000 | 4 | NIH | 11/9/2023 | $581,013 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK130331 | Lipid metabolism and adipose tissue function | 001 | 3 | NIH | 5/17/2024 | $30,295 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK130331 | Lipid metabolism and adipose tissue function | 000 | 3 | NIH | 11/29/2023 | $454,414 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | U01HL152967 | Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices. | 001 | 4 | NIH | 6/24/2024 | $50,651 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | U01HL152967 | Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices. | 000 | 4 | NIH | 11/21/2023 | $569,838 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG076163 | Regulation of the lymphoid cell fate by Hoxa9 | 001 | 3 | NIH | 5/2/2024 | $31,800 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG076163 | Regulation of the lymphoid cell fate by Hoxa9 | 000 | 3 | NIH | 12/8/2023 | $286,200 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK133401 | Heme-mediated Mitochondrial Injury, Senescence, Acute Kidney Injury and Chronic Kidney Disease | 001 | 2 | NIH | 5/6/2024 | $35,950 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK133401 | Heme-mediated Mitochondrial Injury, Senescence, Acute Kidney Injury and Chronic Kidney Disease | 000 | 2 | NIH | 1/24/2024 | $539,257 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K23HL146741 | Psychological support based on positive suggestions in acute respiratory failure patients | 000 | 5 | NIH | 11/8/2023 | $185,760 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA248288 | Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk | 001 | 4 | NIH | 4/18/2024 | $49,517 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA248288 | Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk | 000 | 4 | NIH | 1/16/2024 | $891,305 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA248147 | Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer | 001 | 4 | NIH | 4/18/2024 | $31,143 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK131685 | Noninvasive assessment of detrusor pressure and dysfunction | 001 | 3 | NIH | 5/15/2024 | $37,364 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA248147 | Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer | 000 | 4 | NIH | 12/13/2023 | $560,622 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01GM136869 | Molecular mechanistic studies of long “noncoding” RNAs in mammalian cell differentiation | 001 | 4 | NIH | 6/25/2024 | $31,800 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R35GM143949 | Fundamental and applied studies of nucleic acids | 001 | 3 | NIH | 6/18/2024 | $39,750 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R35GM143949 | Fundamental and applied studies of nucleic acids | 000 | 3 | NIH | 1/23/2024 | $357,750 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL160761 | Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology | 001 | 3 | NIH | 6/24/2024 | $50,844 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL160761 | Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology | 000 | 3 | NIH | 11/28/2023 | $571,997 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA266344 | Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines | 002 | 3 | NIH | 4/17/2024 | $31,600 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA266344 | Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines | 001 | 3 | NIH | 12/15/2023 | $568,795 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK059597 | Investigation of common disease mechanisms in nonsyndromic and syndromic PKD | 001 | 23 | NIH | 5/10/2024 | $35,298 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK059597 | Investigation of common disease mechanisms in nonsyndromic and syndromic PKD | 000 | 23 | NIH | 12/6/2023 | $529,467 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL166238 | Electrochemical Catheter for Prevention of Central Line-Associated Bloodstream Infection | 000 | 2 | NIH | 1/17/2024 | $382,186 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL160570 | Hydrogen Sulfide in Neonatal Airway Disease | 001 | 2 | NIH | 6/12/2024 | $47,711 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL160570 | Hydrogen Sulfide in Neonatal Airway Disease | 000 | 2 | NIH | 11/13/2023 | $536,787 |
| 2024 | 2024 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA283317 | Determinants of toxicity and response to immune checkpoint blockade through integrative profiling of T cell clonal dynamics and plasma cell- free DNA | 000 | 1 | NIH | 6/7/2024 | $711,704 |
|